TY  - GEN
AU  - Espinel-Ingroff,A
AU  - Arendrup,M C
AU  - Pfaller,M A
AU  - Bonfietti,L X
AU  - Bustamante,B
AU  - Canton,E
AU  - Chryssanthou,E
AU  - Cuenca-Estrella,M
AU  - Dannaoui,E
AU  - Fothergill,A
AU  - Fuller,J
AU  - Gaustad,P
AU  - Gonzalez,G M
AU  - Guarro,J
AU  - Lass-Flörl,C
AU  - Lockhart,S R
AU  - Meis,J F
AU  - Moore,C B
AU  - Ostrosky-Zeichner,L
AU  - Pelaez,T
AU  - Pukinskas,S R B S
AU  - St-Germain,G
AU  - Szeszs,M W
AU  - Turnidge,J
TI  - Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
SN  - 1098-6596
PY  - 2014///1222
KW  - Anidulafungin
KW  - Antifungal Agents
KW  - therapeutic use
KW  - Candida
KW  - drug effects
KW  - Candidiasis
KW  - drug therapy
KW  - Caspofungin
KW  - Drug Resistance, Fungal
KW  - Echinocandins
KW  - Europe
KW  - Humans
KW  - Lipopeptides
KW  - Micafungin
KW  - Microbial Sensitivity Tests
KW  - standards
KW  - North America
KW  - Observer Variation
KW  - South America
KW  - Species Specificity
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1128/AAC.01519-13
ER  -